You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 276 No. 24, December 25, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorials
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Selenium and Cancer Prevention

Promising Results Indicate Further Trials Required

Graham A. Colditz, MBBS, DrPH

JAMA. 1996;276(24):1984-1985.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Despite advances in diagnosis and treatment, morbidity and mortality from cancer continue to represent a major health burden. Given the potentially devastating consequences and the fear associated with a diagnosis of cancer, it is not surprising that physicians, patients, and the public may hold substantial optimism for and have considerable interest in seemingly simple and relatively easily implemented measures, such as dietary modification or use of vitamin and trace element supplementation, that appear rapidly effective for cancer prevention. Previous studies examining the potential effects of dietary supplements, such as antioxidant vitamins1,2 for prevention of cancer, have produced mixed results. In this issue of THE JOURNAL, Clark and colleagues3 present promising but preliminary findings from a randomized trial evaluating the possible effectiveness of selenium supplementation for cancer prevention.

See also p 1957.

The Nutritional Prevention of Cancer Study by Clark et al3 randomized 1312 patients to receive placebo . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Medicine, Brigham and Women's Hospital and Harvard Center for Cancer Prevention, Harvard Medical School, Boston, Mass.


Footnotes

Corresponding author: Graham A. Colditz, MBBS, DrPH, Channing Laboratory, 181 Longwood Ave, Boston, MA 02115.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.